https://it.marketscreener.com/quotazioni/azione/NEXIMMUNE-INC-118850398/attualita/Neximmune-annuncia-i-primi-dati-positivi-dello-studio-di-Fase-1-di-NEXI-001-per-la-leucemia-mieloide-44048109/?utm_source=telegram&utm_medium=social&utm_campaign=share